Skip to content

Clinical trials

Phase 3 Granulomatosis with Polyangiitis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Granulomatosis with Polyangiitis Phase: Phase 3 Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20081
20101
20111
20121
20132
20142
20152
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting2
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris4
University of Pennsylvania2
University of South Florida2
Cambridge University Hospitals NHS Foundation Trust1
Hospices Civils de Lyon1
Human Genome Sciences Inc., a GSK Company1
Nordic Pharma SAS1
Ottawa Hospital Research Institute1
UMC Utrecht1
University Medical Center Groningen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Granulomatosis with Polyangiitis15
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis12
Microscopic Polyangiitis9
Vasculitis8
Systemic Vasculitis3
Lung Diseases2
Respiratory Tract Diseases2
Vascular Diseases2
Arthritis, Rheumatoid1
Autoimmune Diseases1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.